BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2077145)

  • 1. Efficacy of combination therapy with mexiletine and a low dose of propranolol for premature ventricular arrhythmias.
    Kobayashi A; Yamazaki N; Kobayashi T; Watanabe T; Ito T; Ogawa K
    Jpn Circ J; 1990 Dec; 54(12):1486-96. PubMed ID: 2077145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of mexiletine in ventricular arrhythmias among patients in Taiwan: assessment by 24-hour Holter electrocardiography.
    Hwang YS; Wang JL
    Clin Ther; 1989; 11(3):392-7. PubMed ID: 2743373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination antiarrhythmic treatment among class Ia, Ib, and II agents for ventricular arrhythmias.
    Tanabe T
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():827-34. PubMed ID: 1931759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of disopyramide and mexiletine used alone or in combination in the treatment of ventricular premature beats.
    Sakurada H; Motomiya T; Hiraoka M
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():835-41. PubMed ID: 1718397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mexiletine. Long-term efficacy and side effects in patients with chronic drug-resistant potentially lethal ventricular arrhythmias.
    Kerin NZ; Aragon E; Marinescu G; Faitel K; Frumin H; Rubenfire M
    Arch Intern Med; 1990 Feb; 150(2):381-4. PubMed ID: 2302013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mexiletine in treatment of chronic ventricular refractary arrhythmias (author's transl)].
    Bellocci F; Ansalone G; Scabbia E; Santarelli P; Lucente M; Affinito V; Loperfido F; Zecchi P
    G Ital Cardiol; 1981; 11(4):488-97. PubMed ID: 6169580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-arrhythmia effectiveness and tolerance of retard in comparison with standard mexiletine].
    Zehender M; Geibel A; Hust M; Hohnloser S; Meinertz T; Just H
    Z Kardiol; 1987 Aug; 76(8):501-6. PubMed ID: 2445118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of mexiletine in ventricular arrhythmias.
    Chaudron JM; Luwaert RJ
    Acta Cardiol; 1985; 40(6):589-98. PubMed ID: 2420104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mexiletine, a new antiarrhythmic agent, for treatment of premature ventricular complexes.
    Mehta J; Conti CR
    Am J Cardiol; 1982 Feb; 49(2):455-60. PubMed ID: 6174042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mexiletine: an effective antiarrhythmic drug for treatment of ventricular arrhythmias in congenital heart disease.
    Moak JP; Smith RT; Garson A
    J Am Coll Cardiol; 1987 Oct; 10(4):824-9. PubMed ID: 3655149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.
    Tanabe T; Takahashi K; Yoshioka K; Goto Y
    Int J Cardiol; 1991 Sep; 32(3):303-12. PubMed ID: 1724233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias.
    Kim SG; Mercando AD; Tam S; Fisher JD
    J Am Coll Cardiol; 1989 Mar; 13(3):659-64. PubMed ID: 2918173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
    Flaker GC; Madigan NP; Alpert MA; Moser SA
    Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study evaluated by Holter monitoring and by mexiletine serum levels in ventricular arrhythmias].
    Meoli P; Sanna GP; Rovelli F
    G Ital Cardiol; 1982; 12(2):115-21. PubMed ID: 6757036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mexiletine in the treatment of ventricular arrhythmias (author's transl)].
    Schlemmer M; Wimmer M
    Padiatr Padol; 1982; 17(2):383-9. PubMed ID: 6179031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose quinidine-mexiletine combination therapy versus quinidine monotherapy for treatment of ventricular arrhythmias.
    Giardina EG; Wechsler ME
    J Am Coll Cardiol; 1990 Apr; 15(5):1138-45. PubMed ID: 2179362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of mexiletine in chronic ventricular arrhythmias: a multicentre double-blind medium-term trial.
    Poggesi L; Scarti L; Ieri A; Lanzetta T; Grazzini M; Del Bene P; Masini G; Del Citerna F; Carnovali M; Masotti G
    Int J Clin Pharmacol Res; 1989; 9(4):269-75. PubMed ID: 2476406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined mexiletine and propranolol treatment of refractory ventricular tachycardia.
    Leahey EB; Heissenbuttel RH; Giardina EG; Bigger JT
    Br Med J; 1980 Aug; 281(6236):357-8. PubMed ID: 7427278
    [No Abstract]   [Full Text] [Related]  

  • 20. Mexiletine therapy in patients with chronic drug-resistant malignant ventricular arrhythmias. Clinical efficacy, safety, and side effects.
    Haggman DL; Maloney JD; Morant VA; Castle LW; King-Rankine M; Goormastic M
    Cleve Clin Q; 1986; 53(2):171-9. PubMed ID: 2874902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.